Brief: Imugene Announce Strategic Research Collaboration
20/07/2023 02:43
July 20 (Reuters) - Imugene Ltd IMU.AX :
* STRATEGIC RESEARCH COLLABORATION TO OPTIMIZE DELIVERY OF
IMUGENE'S ONCOLYTIC VIRUS THERAPY WITH RENOVORX'S TAMP THERAPY
PLATFORM
Source text for Eikon: ID:nASXKv4PT
Further company coverage: IMU.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Imugene
See all newsAustralia's Imugene rises on fresh responses in blood cancer drug trial
Brief: Imugene Ltd Says Leslie Chong Resigns As CEO
Australia's Imugene loses most in over 8-years on discounted placement
Brief: Imugene To Raise A$11.12 Million Via Placement At A$0.095 Per Share
Brief: Imugene Requests Trading Halt Pending Proposed Capital Raising Announcement